Knowledge Empowering PeopleEMPOWERING PEOPLE TO MAKE THE RIGHT DECISIONS ABOUT THEIR HEALTHMaking better and faster informed decisionACCELERATE DIAGNOSTICS TURNAROUND TIME
AT A FRACTION OF THE COSTTurning informed decisions
into empowering peopleDIAGNOSTICS WITH RAPID & UNCOMPROMISING ACCURACY Providing Advanced Medical
Technology For AllREDEFINING HEALTHCARE FOR HUMAN CLINICAL MANAGEMENT
Previous slide
Next slide
Bringing you the gold standard of laboratory testing to every patient’s point-of-needs.
Providing real-time PCR results in 20 minutes from sample to results, anywhere.
Enabling rapid clinical decision-making through data management and triage at the Point-of-Care testing.
VitaSIRO solo™
Bringing you the gold standard of laboratory testing to every patient’s point-of-needs.
VitaPCR™
Providing real-time PCR results in 20 minutes from sample to results, anywhere.
VitaDataLink™
Enabling rapid clinical decision-making through data management and triage at the Point-of-Testing.
Making better and faster informed decisions
Accelerate diagnostics turnaround time at a fraction of the cost
Turning informed decisions into empowering people
Diagnostics with rapid and uncompromising accuracy
Turning informed decisions into empowering people
Diagnostics with rapid and uncompromising accuracy
Providing advanced medical technology for all
Redefining healthcare for human clinical management
Laboratory Professional
Healthcare
Provider
Health System Administrator
ABOUT CREDO DIAGNOSTICS
Knowledge Empowering People
Since 2011, Credo Diagnostics has been dedicated to researching and developing revolutionary diagnostic technologies. We have created, manufactured, and commercialized accurate, rapid, and affordable molecular diagnostic solutions for point-of-care testing.
OUR REACH
Making a positive impact on the lives of billions of people around the globe
The VitaPCR™ NAAT harboured excellent practicability and analytical performances in case of significant contagiousness, which makes it suitable to be used as point-of-care NAAT in various hospital and non-hospital settings where rapid molecular diagnosis of SARS-CoV-2 s necessary.
Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
As a single device can test only one sample at a time, we deployed 16 devices in the Timone hospital emergency ward in order to be able to diagnose people presenting to the emergency room as quickly as possible.
Contagion Management at the Mediterranee Infection University Hospital Institute
Both NAATs showed comparable usability and sensitivities (VitaPCR™: 95.0%; Expert® Press:97.5% and specificities (100% for influenza A/B RNA detection, with excellent reliability and accuracy.
Comparative practicability and analytical performances of VitaPCR™ Flu A&B and Cepheid Xpert® Express Flu/RSV platforms
The VitaPCR™ is a highly sensitive test that enables to deliver results in less than half an hour and to decentralize testing for SARS-CoV-2 in acute-care hospitals or emergency departments where rapid triage decisions are required.
Contribution of VitaPCR™ SARS-CoV-2 to the emergency diagnosis of COVID-19
Previous
Next
LATEST
Media News & Product Updates
Keep Abreast with the Latest
